Tokyo, Japan, June 21, 2013 – Sandoz today announces the National Health Insurance price listing and launch in Japan of sodium risedronate tablets 2.5mg/17.5 mg [Sandoz], the generic version of BENET® Tablets / ACTONEL® Tab. Sodium risedronate tablets 2.5mg/17.5 mg are indicated for the treatment of osteoporosis. “Sandoz is proud to launch this important generic medicine, […]
June 19, 2013 – Sandoz is pleased that the European Medicines Agency (EMA) has issued a draft revised guideline on non-clinical and clinical issues in biosimilar product development. Overall, the draft revised guideline demonstrates EMA’s continued worldwide leadership in biosimilar regulations by applying science in a risk-based manner that safeguards patient safety without compromising access to […]
Lancaster General Health Unveils Leading Robotic Radiosurgery System SUNNYVALE, Calif., June 13, 2013 – Accuray Incorporated (Nasdaq: ARAY) announced today that Lancaster General Health in Pennsylvania is the first U.S. center to treat a patient with the CyberKnife® M6™ System, the most advanced robotic radiosurgery system in the world and the latest generation of the […]
Advanced Radiation Treatment Now Available to Cancer Patients in France SUNNYVALE, Calif., June 5, 2013 – Accuray Incorporated (Nasdaq: ARAY), announced today the first patient has been treated with its new TomoHDA™ System at Centre Oscar Lambret in Lille, France. Building upon the proven TomoTherapy® Hi-Art® and TomoHD™ technologies, the TomoHDA System is a fully-integrated […]
Princeton, New Jersey, May 22, 2013 – Sandoz today announced the US Food and Drug Administration (FDA) approval and US launch of candesartan cilexetil tablets, the first generic version of ATACAND®. Candesartan cilexetil tablets are indicated to treat some types of heart failure in adults with left ventricular systolic dysfunction, and hypertension in adults and children […]
Updated ASTRO Model Policy Endorses Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer SUNNYVALE, Calif., May 21, 2013 – Accuray Incorporated (Nasdaq: ARAY), announced today the publication of study results involving hundreds of prostate cancer patients treated with the CyberKnife® Robotic Radiosurgery System, the most widely used form of prostate stereotactic body radiation therapy (SBRT). […]
The radiotherapy treatment planning system Oncentra® Brachy offers the latest and most advanced tools to make the best possible brachytherapy plan. At the same time, it offers simplicity in radiotherapy treatment planning. The system fits in each unique workflow and expedites the treatment planning process. More complete than ever Oncentra Brachy is now more complete […]
SUNNYVALE, Calif., April 18, 2013 – Accuray Incorporated (Nasdaq: ARAY) announced today clarification on two voluntary recalls that the company initiated on March 19, 2013. In keeping with its commitment to patient safety and total quality management, Accuray has voluntarily implemented a recall of two separate components from its CyberKnife® product line: the Iris™ Variable […]
Heidelberg University Hospital pioneers use; providing precise and efficient treatments SUNNYVALE, Calif., April 4, 2013 – Accuray Incorporated (Nasdaq: ARAY), announced today that Heidelberg University Hospital, Germany, has treated the world’s first patients with the new TomoEDGE™ Dynamic Jaws technology combined with VoLO™ Planning as part of its TomoTherapy® System. The new TomoEDGE Dynamic jaws […]
SUNNYVALE, Calif., March 28, 2013 – Accuray Incorporated (Nasdaq: ARAY), announced today the appointment of Emad Rizk, M.D. to the company’s Board of Directors, effective March 15, 2013. Dr. Rizk is a renowned healthcare industry expert who brings more than 25 years of experience working with payers, hospital systems, government, physicians and pharmaceutical companies to […]